Evidence map›Paper›PMID 37461674›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Informing pandemic response in the face of uncertainty.

Emily Howerton, Lucie Contamin, Luke C Mullany, Michelle Qin, Nicholas G Reich, Samantha Bents, Rebecca K Borchering, Sung-Mok Jung, Sara L Loo, Claire P Smith and 74 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

84 authors.

Emily HowertonThe Pennsylvania State University (PSU)).
Lucie ContaminUniversity of Pittsburgh.
Luke C MullanyJohns Hopkins University Applied Physics Lab (JHU/APL).
Michelle QinHarvard University.
Nicholas G ReichUniversity of Massachusetts Amherst.
Samantha BentsNational Institutes of Health Fogarty International Center (NIH).
Rebecca K BorcheringPSU, Centers for Disease Control and Prevention (CDC).
Sung-Mok JungUniversity of North Carolina (UNC).
Sara L LooJohns Hopkins University Infectious Disease Dynamics (JHU-IDD).
Claire P SmithJohns Hopkins University Infectious Disease Dynamics (JHU-IDD).
John LevanderUniversity of Pittsburgh (UPitt).
Jessica KerrUPitt.
J EspinoUPitt.
Willem G van PanhuisNational Institute of Allergy and Infectious Diseases.
Harry HochheiserUPitt.
Marta GalantiColumbia University (CU).
Teresa YamanaCU.
Sen PeiCU.
Jeffrey ShamanCU.
Kaitlin Rainwater-LovettJHU/APL.
Matt KinseyJHU/APL.
Kate TallaksenJHU/APL.
Shelby WilsonJHU/APL.
Lauren ShinJHU/APL.
Joseph C LemaitreUNC.
Joshua KaminskyJHU-IDD.
Juan Dent HulseJHU-IDD.
Elizabeth C LeeJHU-IDD.
Clif McKeeJHU-IDD.
Alison HillJHU-IDD.
Dean KarlenUniversity of Victoria (UVic).
Matteo ChinazziNortheastern University (NEU).
Jessica T DavisNEU.
Kunpeng MuNEU.
Xinyue XiongNEU.
Ana Pastore Y PionttiNEU.
Alessandro VespignaniNEU.
Erik T RosenstromNorth Carolina State University (NCSU).
Julie S IvyNCSU.
Maria E MayorgaNCSU.
Julie L SwannNCSU.
Guido EspañaUniversity of Notre Dame (UND).
Sean CavanyUND.
Sean MooreUND.
Alex PerkinsUND.
Thomas HladishUniversity of Florida (UF).
Alexander PillaiUF.
Kok Ben TohNorthwestern University.
Ira LonginiUF.
Shi ChenUniversity of North Carolina at Charlotte (UNCC).
Rajib PaulUNCC.
Daniel JaniesUNCC.
Jean-Claude ThillUNCC.
Anass BouchnitaUniversity of Texas at El Paso (UTEP).
Kaiming BiUniversity of Texas at Austin (UTA).
Michael LachmannSanta Fe Institute (SFI).
Spencer FoxUniversity of Georgia (UGA).
Lauren Ancel MeyersUTA.
UT COVID-19 Modeling Consortium
Ajitesh SrivastavaUniversity of Southern California.
Przemyslaw PorebskiUniversity of Virginia (UVA).
Srini VenkatramananUVA.
Aniruddha AdigaUVA.
Bryan LewisUVA.
Brian KlahnUVA.
Joseph OuttenUVA.
Benjamin HurtUVA.
Jiangzhuo ChenUVA.
Henning MortveitUVA.
Amanda WilsonUVA.
Madhav MaratheUVA.
Stefan HoopsUVA.
Parantapa BhattacharyaUVA.
Dustin MachiUVA.
Betsy L CadwellCDC.
Jessica M HealyCDC.
Rachel B SlaytonCDC.
Michael A JohanssonCDC.
Matthew BiggerstaffCDC.
Shaun TrueloveJHU-IDD.
Michael C RungeU.S. Geological Survey.
Katriona SheaPSU.
Cécile ViboudNIH.
Justin LesslerUNC.

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
MIDAS Coordination CenterU24GM132013 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOCHHEISER, HARRY S · 2019 to 2023
$8.1M
Accelerating viral outbreak detection in US cities using mechanistic models, machine learning and diverse geospatial dataR01AI151176 · NIAID · YALE UNIVERSITY · PI GALVANI, ALISON P, MEYERS, LAUREN ANCEL · 2020 to 2024
$3.9M
Systems Analysis of Social Pathways of Epidemics to Reduce Health DisparitiesR01GM109718 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI MARATHE, ACHLA, VULLIKANTI, ANIL · 2014 to 2022
$3.6M
RFA-IP-20-003, FluMod - Center for the Multiscale Modeling of Pandemic and seasonal Flu Prevention and ControlU01IP001137 · IP · NORTHEASTERN UNIVERSITY · PI VESPIGNANI, ALESSANDRO · 2020 to 2024
$3.4M
RFA-IP-22-004, Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenzaU01IP001136 · IP · UNIVERSITY OF TEXAS AT AUSTIN · PI MEYERS, LAUREN ANCEL · 2020 to 2024
$3.4M
Merging machine learning and mechanistic models to improve prediction and inference in emerging epidemicsR01GM140564 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EDWARDS, JESSIE, LESSLER, JUSTIN · 2021 to 2024
$1.8M
ACL HHS U01IP001136ACL HHS U01IP001137NCATS NIH HHS UL1 TR002489NCIRD CDC HHS U01 IP001136NCIRD CDC HHS U01 IP001137NIAID NIH HHS R01 AI151176NIGMS NIH HHS R01 GM109718NIGMS NIH HHS R01 GM140564NIGMS NIH HHS U24 GM132013
6 · The paper itself

Abstract

Our ability to forecast epidemics more than a few weeks into the future is constrained by the complexity of disease systems, our limited ability to measure the current state of an epidemic, and uncertainties in how human action will affect transmission. Realistic longer-term projections (spanning more than a few weeks) may, however, be possible under defined scenarios that specify the future state of critical epidemic drivers, with the additional benefit that such scenarios can be used to anticipate the comparative effect of control measures. Since December 2020, the U.S. COVID-19 Scenario Modeling Hub (SMH) has convened multiple modeling teams to make 6-month ahead projections of the number of SARS-CoV-2 cases, hospitalizations and deaths. The SMH released nearly 1.8 million national and state-level projections between February 2021 and November 2022. SMH performance varied widely as a function of both scenario validity and model calibration. Scenario assumptions were periodically invalidated by the arrival of unanticipated SARS-CoV-2 variants, but SMH still provided projections on average 22 weeks before changes in assumptions (such as virus transmissibility) invalidated scenarios and their corresponding projections. During these periods, before emergence of a novel variant, a linear opinion pool ensemble of contributed models was consistently more reliable than any single model, and projection interval coverage was near target levels for the most plausible scenarios (e.g., 79% coverage for 95% projection interval). SMH projections were used operationally to guide planning and policy at different stages of the pandemic, illustrating the value of the hub approach for long-term scenario projections.

Identifiers

PMID37461674
PMCPMC10350156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.